Cyclerion Therapeutics to Host Pipeline Update Webinar
Company to discuss clinical updates for CY6463, including Phase 2a studies in ADv and MELAS, and plans to initiate Phase 1b clinical trial in CIAS Neuropsychiatric key opinion leader, Andreas Reif, M.D. to discuss role of sGC pathway in CIAS Webcast …